Purple Biotech Ltd (PPBT) — Financial Flexibility Index
Purple Biotech Ltd (PPBT) has a Financial Flexibility Index of -0.17x as of September 2025. Free cash flow of ILA-1.07 Million (operating CF ILA-1.07 Million minus capex ILA0.00) represents 0% of total liabilities (ILA6.25 Million). Check how tangible is Purple Biotech Ltd's equity to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Purple Biotech Ltd Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Purple Biotech Ltd across 8 annual periods. For the full cash flow conversion analysis, see Purple Biotech Ltd operating cash flow efficiency.
Annual Financial Flexibility Index for Purple Biotech Ltd (2017–2024)
Year-by-year free cash flow to debt coverage for Purple Biotech Ltd. Explore PPBT operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (ILA) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.48x | ILA-14.37 Million | ILA-14.37 Million | ILA4.13 Million | ▼ -74.8% |
| 2023 | -1.99x | ILA-19.92 Million | ILA-19.93 Million | ILA10.01 Million | ▲ +10.3% |
| 2022 | -2.22x | ILA-16.71 Million | ILA-16.73 Million | ILA7.52 Million | ▲ +25.3% |
| 2021 | -2.97x | ILA-15.14 Million | ILA-15.25 Million | ILA5.09 Million | ▼ -0.9% |
| 2020 | -2.95x | ILA-11.94 Million | ILA-12.09 Million | ILA4.05 Million | ▼ -104.1% |
| 2019 | -1.44x | ILA-5.57 Million | ILA-5.58 Million | ILA3.86 Million | ▲ +36.6% |
| 2018 | -2.28x | ILA-8.46 Million | ILA-8.48 Million | ILA3.72 Million | ▼ -47.7% |
| 2017 | -1.54x | ILA-8.61 Million | ILA-8.63 Million | ILA5.59 Million | — |